60.13
1.68 (2.87%)
| Penutupan Terdahulu | 58.45 |
| Buka | 58.71 |
| Jumlah Dagangan | 677,632 |
| Purata Dagangan (3B) | 1,308,737 |
| Modal Pasaran | 3,686,672,896 |
| Harga / Jualan (P/S) | 9.11 |
| Harga / Buku (P/B) | 7.95 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 May 2026 |
| Margin Keuntungan | -54.98% |
| Margin Operasi (TTM) | -44.79% |
| EPS Cair (TTM) | -3.25 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 23.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 18.25% |
| Nisbah Semasa (MRQ) | 4.51 |
| Aliran Tunai Operasi (OCF TTM) | -56.11 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -16.89 M |
| Pulangan Atas Aset (ROA TTM) | -15.04% |
| Pulangan Atas Ekuiti (ROE TTM) | -38.22% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Twist Bioscience Corporation | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -3.0 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | -1.00 |
|
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.98% |
| % Dimiliki oleh Institusi | 115.15% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Edgepoint Investment Group Inc. | 31 Dec 2025 | 5,377,991 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 52.00 (Evercore ISI Group, -13.52%) | Beli |
| Median | 51.00 (-15.18%) | |
| Rendah | 50.00 (Barclays, -16.85%) | Beli |
| Purata | 51.00 (-15.18%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 46.32 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 03 Feb 2026 | 50.00 (-16.85%) | Beli | 46.32 |
| Evercore ISI Group | 03 Feb 2026 | 52.00 (-13.52%) | Beli | 46.32 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| FINN PATRICK JOHN | - | 58.85 | -2,321 | -136,591 |
| LEPROUST EMILY M. | - | 62.91 | -9,671 | -610,257 |
| STAROVASNIK MELISSA A. | - | 61.00 | -500 | -30,500 |
| Jumlah Keseluruhan Kuantiti Bersih | -12,492 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -777,348 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 61.42 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| STAROVASNIK MELISSA A. | Pengarah | 27 Apr 2026 | Jual automatik (-) | 500 | 61.00 | 30,500 |
| FINN PATRICK JOHN | Pegawai | 23 Apr 2026 | Jual (-) | 2,321 | 58.85 | 136,591 |
| LEPROUST EMILY M. | Pegawai | 22 Apr 2026 | Jual automatik (-) | 8,061 | 63.20 | 509,455 |
| LEPROUST EMILY M. | Pegawai | 22 Apr 2026 | Pelaksanaan pilihan | 8,061 | - | - |
| LEPROUST EMILY M. | Pegawai | 21 Apr 2026 | Jual automatik (-) | 1,610 | 62.61 | 100,802 |
| LEPROUST EMILY M. | Pegawai | 21 Apr 2026 | Pelaksanaan pilihan | 1,610 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Feb 2026 | Pengumuman | Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) |
| 02 Feb 2026 | Pengumuman | Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |